The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia

In previous work we evaluated an opioid glycopeptide with mixed μ/δ-opioid receptor agonism that was a congener of leu-enkephalin, MMP-2200. The glycopeptide analogue showed penetration of the blood–brain barrier (BBB) after systemic administration to rats, as well as profound central effects in mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartlett, Mitchell J., Mabrouk, Omar S., Szabò, Lajos, Flores, Andrew J., Parent, Kate L., Bidlack, Jean M., Heien, Michael L., Kennedy, Robert T., Polt, Robin, Sherman, Scott J., Falk, Torsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792611/
https://www.ncbi.nlm.nih.gov/pubmed/33374986
http://dx.doi.org/10.3390/ijms22010020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792611/
https://www.ncbi.nlm.nih.gov/pubmed/33374986
http://dx.doi.org/10.3390/ijms22010020

Ejemplares similares